Process View
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels and contribute to the series of events that restore integrity to a damaged tissue, following an injury.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "angiogenesis involved in wound healing"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 1.000 | ||
FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 1.000 | ||
PLAU | plasminogen activator, urokinase | 1.000 | ||
NRP1 | neuropilin 1 | 1.000 | ||
PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 1.000 | ||
KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.999 | ||
COL4A1 | collagen, type IV, alpha 1 | 0.999 | ||
PLAT | plasminogen activator, tissue | 0.993 | ||
PDGFA | platelet-derived growth factor alpha polypeptide | 0.977 | Human | |
COL4A2 | collagen, type IV, alpha 2 | 0.976 | ||
TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.967 | ||
PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.949 | Human | |
COL5A1 | collagen, type V, alpha 1 | 0.936 | ||
PLAUR | plasminogen activator, urokinase receptor | 0.917 | ||
ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.862 | ||
ENG | endoglin | 0.813 | ||
PTPRB | protein tyrosine phosphatase, receptor type, B | 0.803 | ||
PDGFC | platelet derived growth factor C | 0.739 | ||
DAXX | death-domain associated protein | 0.726 | ||
PLCG1 | phospholipase C, gamma 1 | 0.672 | ||
THBS1 | thrombospondin 1 | 0.601 | ||
COL6A1 | collagen, type VI, alpha 1 | 0.590 | ||
SP100 | SP100 nuclear antigen | 0.580 | ||
COL1A1 | collagen, type I, alpha 1 | 0.572 | ||
STC1 | stanniocalcin 1 | 0.469 | ||
VEGFA | vascular endothelial growth factor A | 0.450 | Human | |
CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.443 | ||
CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.439 | ||
TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.433 | ||
PXDN | peroxidasin homolog (Drosophila) | 0.419 | ||
TGFB1I1 | transforming growth factor beta 1 induced transcript 1 | 0.301 | ||
COL1A2 | collagen, type I, alpha 2 | 0.266 | ||
CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.260 | ||
PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.223 | ||
HSPG2 | heparan sulfate proteoglycan 2 | 0.216 | ||
DDIT4 | DNA-damage-inducible transcript 4 | 0.203 | ||
CAV1 | caveolin 1, caveolae protein, 22kDa | 0.202 | ||
LAMA5 | laminin, alpha 5 | 0.181 | ||
CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.176 | ||
SPHK1 | sphingosine kinase 1 | 0.158 | ||
OSMR | oncostatin M receptor | 0.154 | ||
TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.148 | ||
ANGPT2 | angiopoietin 2 | 0.147 | ||
RASSF1 | Ras association (RalGDS/AF-6) domain family member 1 | 0.137 | ||
LDLR | low density lipoprotein receptor | 0.127 | ||
TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.127 | ||
SPARC | secreted protein, acidic, cysteine-rich (osteonectin) | 0.126 | ||
TNC | tenascin C | 0.118 | ||
IGFBP5 | insulin-like growth factor binding protein 5 | 0.117 | ||
FZD4 | frizzled homolog 4 (Drosophila) | 0.115 | ||
COL3A1 | collagen, type III, alpha 1 | 0.114 | ||
INHBA | inhibin, beta A | 0.112 | ||
COL6A2 | collagen, type VI, alpha 2 | 0.105 | ||
ORM1 | orosomucoid 1 | 0.104 | ||
CSPG4 | chondroitin sulfate proteoglycan 4 | 0.102 | ||
BHLHE40 | basic helix-loop-helix family, member e40 | 0.096 | ||
TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0.086 | ||
VWF | von Willebrand factor | 0.084 | ||
SLC6A8 | solute carrier family 6 (neurotransmitter transporter, creatine), member 8 | 0.083 | ||
ERG | v-ets erythroblastosis virus E26 oncogene homolog (avian) | 0.079 | ||
VEGFC | vascular endothelial growth factor C | 0.076 | Human | |
TGFB1 | transforming growth factor, beta 1 | 0.073 | ||
SRPX | sushi-repeat containing protein, X-linked | 0.071 | ||
FLT4 | fms-related tyrosine kinase 4 | 0.069 | ||
NRP2 | neuropilin 2 | 0.068 | ||
TEK | TEK tyrosine kinase, endothelial | 0.062 | ||
BGN | biglycan | 0.059 | ||
ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.058 | ||
IER3 | immediate early response 3 | 0.054 | ||
EPAS1 | endothelial PAS domain protein 1 | 0.053 | ||
CCL2 | chemokine (C-C motif) ligand 2 | 0.053 | ||
FOSL2 | FOS-like antigen 2 | 0.051 | ||
RFWD2 | ring finger and WD repeat domain 2 | 0.051 | ||
ANGPTL4 | angiopoietin-like 4 | 0.051 | ||
IGFBP4 | insulin-like growth factor binding protein 4 | 0.050 | ||
EMCN | endomucin | 0.050 | ||
ANGPTL2 | angiopoietin-like 2 | 0.050 | ||
GJA4 | gap junction protein, alpha 4, 37kDa | 0.049 | ||
LRRC32 | leucine rich repeat containing 32 | 0.049 | ||
PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.048 | ||
COL18A1 | collagen, type XVIII, alpha 1 | 0.047 | ||
GPRC5A | G protein-coupled receptor, family C, group 5, member A | 0.046 | ||
NPC2 | Niemann-Pick disease, type C2 | 0.046 | ||
FADS3 | fatty acid desaturase 3 | 0.046 | ||
NNMT | nicotinamide N-methyltransferase | 0.046 | ||
BCL3 | B-cell CLL/lymphoma 3 | 0.045 | ||
COL16A1 | collagen, type XVI, alpha 1 | 0.044 | ||
PVRL2 | poliovirus receptor-related 2 (herpesvirus entry mediator B) | 0.044 | ||
AXL | AXL receptor tyrosine kinase | 0.042 | ||
COL2A1 | collagen, type II, alpha 1 | 0.042 | ||
MCAM | melanoma cell adhesion molecule | 0.041 | ||
WHSC1L1 | Wolf-Hirschhorn syndrome candidate 1-like 1 | 0.041 | ||
THBD | thrombomodulin | 0.040 | ||
ESAM | endothelial cell adhesion molecule | 0.039 | ||
MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.039 | ||
FOSL1 | FOS-like antigen 1 | 0.038 | ||
GPR116 | G protein-coupled receptor 116 | 0.038 | ||
TGFB2 | transforming growth factor, beta 2 | 0.037 | ||
NID1 | nidogen 1 | 0.037 | ||
MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.035 | ||
JAG1 | jagged 1 | 0.034 | ||
LOXL2 | lysyl oxidase-like 2 | 0.033 | ||
RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.032 | ||
TGFB3 | transforming growth factor, beta 3 | 0.031 | ||
IGFBP7 | insulin-like growth factor binding protein 7 | 0.031 | ||
SPOP | speckle-type POZ protein | 0.030 | ||
PPDPF | pancreatic progenitor cell differentiation and proliferation factor homolog (zebrafish) | 0.029 | ||
MYL9 | myosin, light chain 9, regulatory | 0.029 | ||
LTBP2 | latent transforming growth factor beta binding protein 2 | 0.028 | ||
TFPI2 | tissue factor pathway inhibitor 2 | 0.028 | ||
MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.028 | ||
MMRN2 | multimerin 2 | 0.027 | ||
ETS2 | v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) | 0.027 | ||
CALCRL | calcitonin receptor-like | 0.027 | ||
PALM | paralemmin | 0.026 | ||
FSTL3 | follistatin-like 3 (secreted glycoprotein) | 0.026 | ||
AEBP1 | AE binding protein 1 | 0.026 | ||
CD248 | CD248 molecule, endosialin | 0.025 | ||
SERPINE2 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 | 0.025 | Human | |
HBEGF | heparin-binding EGF-like growth factor | 0.025 | ||
SERPINH1 | serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) | 0.025 | ||
CHST3 | carbohydrate (chondroitin 6) sulfotransferase 3 | 0.024 | ||
ZNF358 | zinc finger protein 358 | 0.024 | ||
MDFI | MyoD family inhibitor | 0.024 | ||
TBX2 | T-box 2 | 0.023 | ||
ACVRL1 | activin A receptor type II-like 1 | 0.023 | ||
NID2 | nidogen 2 (osteonidogen) | 0.022 | ||
ICAM1 | intercellular adhesion molecule 1 | 0.022 | ||
LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.022 | ||
NOTCH4 | notch 4 | 0.022 | ||
IL6 | interleukin 6 (interferon, beta 2) | 0.022 | ||
TAL1 | T-cell acute lymphocytic leukemia 1 | 0.021 | ||
LAMB2 | laminin, beta 2 (laminin S) | 0.021 | ||
PCDH12 | protocadherin 12 | 0.020 | ||
AES | amino-terminal enhancer of split | 0.020 | ||
PDE2A | phosphodiesterase 2A, cGMP-stimulated | 0.020 | ||
BMP4 | bone morphogenetic protein 4 | 0.020 | ||
CD93 | CD93 molecule | 0.020 | ||
PECAM1 | platelet/endothelial cell adhesion molecule | 0.020 | ||
SPSB1 | splA/ryanodine receptor domain and SOCS box containing 1 | 0.019 | ||
STC2 | stanniocalcin 2 | 0.019 | ||
TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.019 | ||
S1PR1 | sphingosine-1-phosphate receptor 1 | 0.019 | ||
ARID4B | AT rich interactive domain 4B (RBP1-like) | 0.019 | ||
PVR | poliovirus receptor | 0.019 | ||
VTN | vitronectin | 0.019 | ||
TNS1 | tensin 1 | 0.019 | ||
ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | 0.019 | ||
CHST11 | carbohydrate (chondroitin 4) sulfotransferase 11 | 0.018 | ||
GFPT2 | glutamine-fructose-6-phosphate transaminase 2 | 0.018 | ||
PML | promyelocytic leukemia | 0.018 | ||
FGFR1 | fibroblast growth factor receptor 1 | 0.018 | ||
EDN1 | endothelin 1 | 0.017 | ||
ELTD1 | EGF, latrophilin and seven transmembrane domain containing 1 | 0.017 | ||
EGFL7 | EGF-like-domain, multiple 7 | 0.017 | ||
TGFBR1 | transforming growth factor, beta receptor 1 | 0.017 | ||
RFNG | RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase | 0.017 | ||
ENPEP | glutamyl aminopeptidase (aminopeptidase A) | 0.017 | ||
PLVAP | plasmalemma vesicle associated protein | 0.017 | ||
THY1 | Thy-1 cell surface antigen | 0.017 | ||
HEG1 | HEG homolog 1 (zebrafish) | 0.017 | ||
ADAMTS9 | ADAM metallopeptidase with thrombospondin type 1 motif, 9 | 0.017 | ||
SLC2A3 | solute carrier family 2 (facilitated glucose transporter), member 3 | 0.016 | ||
AQP1 | aquaporin 1 (Colton blood group) | 0.016 | ||
GAS6 | growth arrest-specific 6 | 0.016 | ||
TCF7L1 | transcription factor 7-like 1 (T-cell specific, HMG-box) | 0.016 | ||
COL5A2 | collagen, type V, alpha 2 | 0.016 | ||
USF2 | upstream transcription factor 2, c-fos interacting | 0.016 | ||
SLCO2A1 | solute carrier organic anion transporter family, member 2A1 | 0.016 | ||
ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.015 | ||
CSF1 | colony stimulating factor 1 (macrophage) | 0.015 | ||
LOX | lysyl oxidase | 0.015 | ||
JAG2 | jagged 2 | 0.015 | ||
EFNA1 | ephrin-A1 | 0.015 | ||
PRRX1 | paired related homeobox 1 | 0.015 | ||
ULBP2 | UL16 binding protein 2 | 0.015 | ||
NT5E | 5'-nucleotidase, ecto (CD73) | 0.015 | ||
FST | follistatin | 0.015 | ||
ECM1 | extracellular matrix protein 1 | 0.015 | ||
ADM | adrenomedullin | 0.015 | ||
RUNX1 | runt-related transcription factor 1 | 0.015 | ||
TNFRSF11B | tumor necrosis factor receptor superfamily, member 11b | 0.015 | ||
DDIT3 | DNA-damage-inducible transcript 3 | 0.015 | ||
PLOD2 | procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 | 0.014 | ||
SPRY1 | sprouty homolog 1, antagonist of FGF signaling (Drosophila) | 0.014 | ||
TUBB6 | tubulin, beta 6 | 0.014 | ||
LRP1 | low density lipoprotein receptor-related protein 1 | 0.014 | ||
COL6A3 | collagen, type VI, alpha 3 | 0.014 | ||
VAT1 | vesicle amine transport protein 1 homolog (T. californica) | 0.014 | ||
PODXL | podocalyxin-like | 0.014 | ||
RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.014 | ||
SEMA3G | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G | 0.014 | ||
HAS2 | hyaluronan synthase 2 | 0.014 | ||
DLC1 | deleted in liver cancer 1 | 0.014 | ||
MYCT1 | myc target 1 | 0.014 | ||
FURIN | furin (paired basic amino acid cleaving enzyme) | 0.013 | ||
MICAL2 | microtubule associated monoxygenase, calponin and LIM domain containing 2 | 0.013 | ||
MMRN1 | multimerin 1 | 0.013 | ||
PKN1 | protein kinase N1 | 0.013 | ||
SORBS3 | sorbin and SH3 domain containing 3 | 0.013 | ||
ESM1 | endothelial cell-specific molecule 1 | 0.013 | ||
ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.012 | ||
FNDC3B | fibronectin type III domain containing 3B | 0.012 | ||
LBH | limb bud and heart development homolog (mouse) | 0.012 | ||
GUCY1A3 | guanylate cyclase 1, soluble, alpha 3 | 0.012 | ||
CSRNP1 | cysteine-serine-rich nuclear protein 1 | 0.012 | ||
PMEPA1 | prostate transmembrane protein, androgen induced 1 | 0.012 | ||
SMTN | smoothelin | 0.012 | ||
COL7A1 | collagen, type VII, alpha 1 | 0.012 | ||
SLC2A4RG | SLC2A4 regulator | 0.012 | ||
GEM | GTP binding protein overexpressed in skeletal muscle | 0.012 | ||
SNTA1 | syntrophin, alpha 1 (dystrophin-associated protein A1, 59kDa, acidic component) | 0.012 | ||
PDLIM4 | PDZ and LIM domain 4 | 0.012 | ||
RAB11B | RAB11B, member RAS oncogene family | 0.012 | ||
ECE1 | endothelin converting enzyme 1 | 0.012 | ||
MFAP2 | microfibrillar-associated protein 2 | 0.011 | ||
SDPR | serum deprivation response | 0.011 | ||
RAI14 | retinoic acid induced 14 | 0.011 | ||
GRB10 | growth factor receptor-bound protein 10 | 0.011 | ||
CXCR7 | chemokine (C-X-C motif) receptor 7 | 0.011 | ||
PHLDA2 | pleckstrin homology-like domain, family A, member 2 | 0.011 | ||
STARD8 | StAR-related lipid transfer (START) domain containing 8 | 0.011 | ||
EXT1 | exostosin 1 | 0.011 | ||
GNG11 | guanine nucleotide binding protein (G protein), gamma 11 | 0.011 | ||
HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0.011 | ||
RGS16 | regulator of G-protein signaling 16 | 0.011 | ||
PROCR | protein C receptor, endothelial | 0.011 | ||
RHOJ | ras homolog gene family, member J | 0.011 | ||
ACE | angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 | 0.011 | ||
UAP1L1 | UDP-N-acteylglucosamine pyrophosphorylase 1-like 1 | 0.010 | ||
IGFBP2 | insulin-like growth factor binding protein 2, 36kDa | 0.010 | ||
CX3CL1 | chemokine (C-X3-C motif) ligand 1 | 0.010 | ||
KIAA1462 | KIAA1462 | 0.010 | ||
LOXL1 | lysyl oxidase-like 1 | 0.010 | ||
MAP4 | microtubule-associated protein 4 | 0.010 | ||
ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | 0.010 | ||
EDIL3 | EGF-like repeats and discoidin I-like domains 3 | 0.010 | ||
F3 | coagulation factor III (thromboplastin, tissue factor) | 0.010 | ||
OLFML2A | olfactomedin-like 2A | 0.010 |